Skip to main content
Premium Trial:

Request an Annual Quote

Boring the Reviewer to Death Isn't a Good Plan

At DrugMonkey, PhysioProf is starting a series on the structure of the research plan of an R01 application. This post looks at the specific aims section of that application. The goal of this page — and it should only be a single page — is "to encapsulate the basic gist of the proposed research and get the reviewer excited. If the reviewer is not excited after reading this page, you are toast," says PhysioProf. The blogger then breaks down what belongs on that page, including an overview of the project, background and preliminary results, and the three specific aims of the project.

 

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.